Abstract Epithelial-mesenchymal transition (EMT) of mammary epithelial cells is important in both normal morphogenesis of mammary glands and metastasis of breast cancer. Cadherin switching from E-cadherin to N-cadherin plays important roles in EMT. We found that cadherin switching is important in bone morphogenetic protein 4 (BMP4)-induced EMT in MCF-10A cells. BMP4 increased the phosphorylation of SMAD proteins in MCF-10A cells. Canonical BMP4 signaling decreased the expression of E-cadherin and disrupted the polarity of the tight junction protein ZO-1 in MCF-10A cells. However, the expression of N-cadherin and SNAI2 was up-regulated in BMP4-treated MCF-10A cells. MCF-10A cells that expressed N-cadherin migrated into type I collagen gels in response to BMP4 when evaluated using three-dimensional culture assays. Thus, active canonical BMP4 signaling is important for the migration and EMT of mammary epithelial cells. Moreover, the decrease in Ecadherin and/or increase in N-cadherin may be required for BMP4-induced migration and EMT.
Introduction
Bone morphogenetic proteins (BMPs) are a subgroup of the transforming growth factor-β (TGF-β) family and play essential roles in tumor metastasis and normal embryonic developmental processes [1] . BMPs transduce signals through both SMAD-dependent (canonical) and SMAD-independent (noncanonical) pathways [1, 2] . In canonical signal transduction pathways, BMPs facilitate the formation of hetero-oligomeric complexes of BMP receptors. Inside the complex, BMP type II receptors phosphorylate BMP type I receptors. Phosphorylated BMP type I receptors are activated and phosphorylate SMAD1/5/9. Phosphorylated SMAD1/5/9 form a complex with SMAD4, and this SMAD complex enters the nucleus and regulates the expression of BMP downstream genes [3] .
TGF-β induces epithelial-mesenchymal transition (EMT) in epithelial cells from various tissues [4] . EMT is an important process that regulates tumor cell metastasis and the development of embryos and organs [5] . Components of epithelial cell polarity such as tight junctions are lost and motility is induced in epithelial cells undergoing EMT [6] . Epithelial cells undergoing EMT are characterized by the loss of cadherin-mediated cell-cell adhesions [6, 5] . Therefore, the regulation of cadherins is important in the EMT process. Down-regulation of E-cadherin is required for EMT of epithelial cells. However, up-regulation of the expression of other types of cadherins is also necessary for EMT [7, 8] . Cadherin switching usually means a switch from expression of Ecadherin to expression of N-cadherin, but it is also able to occur during the cadherin switching process that the expression level of N-cadherin increases in cells without change in the expression level of E-cadherin [7] . Many studies have suggested that cadherin switching (usually from expression of E-cadherin to expression of N-cadherin) is frequently observed in the EMT process and is a fundamental factor in normal development and pathological processes [7, 9] . TGF-β induces motility of MCF-10A cells and cadherin switching (from E-cadherin to N-cadherin) in the cells [10] . However, siRNA-mediated knockdown of Ncadherin inhibits the motility of MCF-10A mediated with TGF-β, and it suggests that the cadherin switching (N-cadherin expression) is required for the motility of MCF-10A [10] . More interestingly, cadherin switching is necessary for BMP signaling-mediated EMT. Cadherin-6B is required for BMP signaling-mediated EMT of neural crest cells, whereas N-cadherin inhibits EMT [8, 11] .
TGF-β family signaling is important in both breast tumorigenesis and mammary gland development [12, 13] . The activation both of SMAD-dependent, canonical signaling [12] and SMAD-independent, non-canonical signaling [14] is important in breast tumorigenesis. BMP genes, including BMP4, are expressed during fetal and postnatal mammary gland development [13] . TGF-β family signaling is also important in cadherin switching in breast cancer [15] . However, to date, it has not been reported that BMP4-mediated canonical signaling would induce EMT of mammary epithelial cells and that cadherin switching from E-cadherin to N-cadherin would occur in cells undergoing BMP4-mediated EMT. Therefore, we wanted to test whether BMP4-mediated canonical signaling can regulate the expression level of E-cadherin and Ncadherin in MCF-10A cells to induce EMT as well as whether cadherin switching is important in BMP4-mediated motility of MCF-10A cells.
Materials and methods

Cell culture
MCF-10A cells (ATCC, Manassas, VA, USA) were cultured in DMEM/F12 (Invitrogen, Carlsbad, CA, USA) supplemented with 5 % horse serum (Invitrogen), 0.5 % hydrocortisone (Sigma-Aldrich, St. Louis, MO, USA), 100 ng/ml cholera toxin (Sigma-Aldrich), 10 μg/ml insulin (Sigma-Aldrich), and 20 ng/ml recombinant human epidermal growth factor (Sigma-Aldrich) at 37°C and 5 % CO 2 . In some experiments, MCF-10A cells were serum-starved (DMEM/F12 supplemented with 5 % bovine albumin [Sigma-Aldrich]) for 18 h and then treated with 50 ng/ml BMP4 (R&D Systems, Minneapolis, MN, USA).
Western blot analysis MCF-10A cells were washed three times with ice-cold phosphate-buffered saline (PBS; Invitrogen), and sodium dodecyl sulfate (SDS) buffer (2×) was directly added to the cells. The cell extracts were then completely denatured by boiling at 95°C for 10 min. Next, proteins were separated by 8 or 10 % SDS-polyacrylamide gel electrophoresis, and Western blotting was carried out using standard procedures. Primary antibodies against phosphorylated SMAD1/5/9 (pSMAD1/5/ 9, Cell Signaling Technology, Beverly, MA, USA), Ecadherin (BD Biosciences, San Jose, CA, USA), N-cadherin (Invitrogen), SMAD1 (Millipore, Darmstadt, Germany), and α-tubulin (Sigma-Aldrich) were used for immunoblotting. If necessary, band densities of E-cadherin, N-cadherin, or SMAD1 were measured with ImageJ (NIH) and normalized to the control level.
Immunofluorescence MCF-10A cells were seeded and cultured on fibronectin (Sigma-Aldrich)-coated cover glasses. Cells were fixed with 4 % paraformaldehyde (Electron Microscopy Science, Hatfield, PA, USA) in PBS for 10 min on ice. Then, immunostaining was performed using standard procedures. Primary antibodies against pSMAD1/5/9 (Cell Signaling Technology), E-cadherin (BD Biosciences), Ncadherin (Invitrogen), ZO-1 (Invitrogen), laminin (SigmaAldrich), and SNAI2 (Santa Cruz Biotechnology, Dallas, TX, USA) were used. When required, phalloidin-Texas red (Molecular Probes, Carlsbad, CA, USA) was used for actin staining and DRAQ5 (Biostatus, Leicestershire, UK) was used for nucleus staining. Cells were imaged using a Nikon Eclipse TE2000 confocal microscope (Nikon Instruments, Inc., Melville, NY).
Real-time PCR
Real-time PCR was performed to quantitatively determine the messenger RNA level of CDH2 and SNAI2 in MCF-10A. Total RNA was extracted from MCF-10A cells treated with 0 or 50 ng/ml BMP4 for 1 day with TRIzol (Invitrogen), according to the manufacturer's protocol. Five micrograms of total RNAwas used for single-strand cDNA synthesis using Superscript First-Strand cDNA Synthesis System (Invitrogen) according to the manufacturer's instructions. Then, quantitative RT-PCR was performed using Power SYBR Green PCR Master Mix (Invitrogen). Human ribosomal protein S9 (RPS9) gene was used as an endogenous control. The following primers were used to detect the expression of CDH2 (a gene of human N-cadherin), SNAI2, and RPS9: CDH2 (sense), 5′-CGGGTAATCCTCCAA AATCA-3′, CDH2 (antisense), 5′-CTTTATCCCGGCCTTTCATC-3′; SNAI2 (sense), 5′-AGATGCATATTCGGACCCAC-3′, SNAI2 (antisense), 5′-CTTCATGTTTGTGCAGGACA-3′; and RPS9 (sense), 5′-CTG ACGCTTGATGAGAAGGAC-3′, and RPS9 (antisense), 5′-CAGCTTCATCTTGCCCTCAT-3′.
Three-dimensional cell culture assay Type I collagen matrix solution was prepared as a mixture of type I collagen solution (8.4 mg/ml, BD Biosciences), reconstitution buffer (2.2 g NaHCO 3 and 200 mM HEPES in 0.05 N NaOH), PBS (5×), and 5 mM CaCl 2 (5:1:2:2). When required, 200 ng/ml of BMP4 was added to the matrix solution. Then, the type I collagen matrix solution was dispensed in 12-mm Millicells (Millipore, Billerica, MA, USA) and incubated overnight at 37°C and 5 % CO 2 . MCF-10A cells were seeded at over-confluent density onto the gels and cultured for 6 days. The culture medium for the BMP4-treated group was supplemented with 200 ng/ml of BMP4. The medium was exchanged every 2 days. For the preparation of cryosections, gels were fixed with 4 % paraformaldehyde in PBS for 15 min on ice, embedded into OCT compound (Tissue-Tek), and sectioned at 10 μm thickness. Then, immunostaining was performed using standard procedures. Cells were imaged using a Nikon Eclipse TE2000 confocal microscope.
Results
BMP4 activates canonical signaling in MCF-10A cells
It is known that mammary epithelial cells express BMP receptors and SMAD molecules [16] . Thus, we examined whether BMP4 can activate canonical BMP signaling in MCF-10A cells, which are normal mammary epithelial cells. Phosphorylation of SMAD1/5/9 started to occur at 10 min after BMP4 treatment (Fig. 1a) . However, the phosphorylation of SMAD1/5/9 gradually decreased within 1 h (Fig. 1a) and was slightly maintained 24 h after BMP4 treatment (Fig. 1b) with no change in the Western blot analysis of phosphorylated SMAD1/5/9 (pSMAD) was performed. a The phosphorylation of SMAD1/5/9 (pSMAD) was detectable 10 min after BMP4 treatment. Alphatubulin (α-Tub) was used as an internal control in Western blots of phosphorylated SMAD1/ 5/9. b The phosphorylation of SMAD1/5/9 was observed 24 h after BMP4 treatment as well as 30 min. Western blot analysis of phosphorylated SMAD1/5/9 (pSMAD) and SMAD1 was performed. α-Tub was used as an internal control in the western blot. c The band intensity of SMAD1 was quantified by ImageJ and normalized to α-tubulin levels. The graph shows fold increase as compared with the levels in the non-treated control group (30 min without BMP4 treatment). Results are shown in mean±SD, and p value was calculated with one-way ANOVA expression level of SMAD1 (Fig. 1b, c) , which means BMP4 treatment did not induce a mechanism of feedback regulation via the regulation of SMAD expression level. Thus, canonical BMP signaling is activated in MCF-10A cells by treatment with BMP4.
BMP4 induces EMT in MCF-10A cells BMP signaling plays important roles in the morphogenesis of mammary glands mediated by the EMT process [13] . Moreover, it has also been suggested that BMP signaling enhances metastasis of breast cancer [17] . Loss of E-cadherin and depolarization of tight junction proteins such as ZO-1 are characteristic for EMT [6] . We found that E-cadherin expression was significantly decreased in cells in which canonical BMP signaling was activated following BMP4 treatment (Fig. 2a, arrows) and the percentage of E-cadherin negative cells increased 5-fold with BMP4 treatment as compared to the control group (Fig. 2b) . We also investigated the subcellular localization of ZO-1. We found that ZO-1 was localized to the cell membrane in MCF-10A cells. However, BMP4 induced the redistribution of ZO-1 from the plasma membrane to the cytoplasm (Fig. 2c, arrows) . Therefore, these results suggest that BMP4-mediated activation of canonical BMP signaling induces EMT in MCF-10A cells.
BMP4 induces cadherin switching from E-cadherin to N-cadherin in MCF-10A cells
We investigated BMP4-induced EMT in MCF-10A cells. Ecadherin expression was down-regulated in cells undergoing EMT. Cadherin switching from E-cadherin to N-cadherin is frequently observed during EMT [7] . Thus, we examined the N-cadherin expression in MCF-10A cells treated with BMP4 for up to 24 h. The activation of canonical BMP signaling was observed after BMP4 treatment (Fig. 3a) . BMP4 treatment slightly decreased E-cadherin expression 24 h after BMP4 treatment, whereas N-cadherin expression increased by BMP4 treatment (Fig. 3a) . Moreover, BMP4 treatment also increased messenger RNA (mRNA) levels of both CDH2, a (50 ng/ml) for 24 h after serum starvation. Phosphorylated SMAD1/5/9 were stained in green (pSMAD), and E-cadherin was stained in red (E-cad). Nuclei were stained in blue by DRAQ5. White arrows indicate E-cadherin negative cells. b To statistically analyze the percentage of E-cadherin negative cells, more than 323 cells were counted in each experimental group after immunostaining against E-cadherin. Results are shown in mean±SD, and p value was calculated with Student's t test. c BMP4 induced the depolarization of ZO-1. MCF-10A cells were treated with BMP4 (50 ng/ml) for 30 min or 24 h after serum starvation. ZO-1 was stained in red. White arrows indicate cells in which ZO-1 is depolarized. Scale bars=25 μm gene of human N-cadherin (Fig. 3b) and SNAI2, one of EMT markers (Fig. 3c) . These results show that canonical BMP4 signaling might induce cadherin switching from E-cadherin to N-cadherin in MCF-10A cells undergoing EMT.
BMP4 induces the migration of MCF-10A cells that undergo cadherin switching
Cadherin switching has been clearly observed in both metastasis of tumor cells and migration of cells during normal developmental processes, e.g., neural crest migration [7] . To examine whether migration of MCF-10A cells is induced by N-cadherin in response to BMP4 treatment, we performed a three-dimensional migration assay on type I collagen gels (Fig. 4a) . Interestingly, MCF-10A cells migrated into type I collagen gels following BMP4 treatment (Fig. 4b-f) . No cells migrate into type I collagen gels without BMP4 treatment, but 8 % of cells migrated into the gels with BMP4 treatment (Fig. 4b) . Phosphorylation of SMAD1/5/9 proteins was detected in BMP4-treated cells (Fig. 4c) . BMP4 treatment induced the expression of SNAI2, which is a master transcription factor to induce EMT [18] (Fig. 4d) . The expression of laminin, another marker of EMT [19] , was significantly increased in migrating cells (Fig. 4e) . The localization of ZO-1 changed in migrating cells. Compared to the control cells, ZO-1 was scattered over the entire cytoplasm in BMP4-treated cells (Fig. 4f) . These results are in very good agreement with those shown in Fig. 2b . None of the migrating MCF-10A cells expressed E-cadherin (Fig. 4e, red) . However, migrating MCF-10A cells expressed N-cadherin (Fig. 4c, red) . Overall, these results suggest that MCF-10A cells undergo cadherin switching and EMT in response to BMP4 and that Ncadherin expression is important in BMP4-mediated migration of MCF-10A cells.
Discussion
To our knowledge, our findings are the first to demonstrate that canonical BMP4 signaling induces EMT in MCF-10A cells (a non-transformed breast epithelial cell line) and increases the expression of N-cadherin, which contributes to the motility of MCF-10A cells induced with BMP4. It is known that BMP4 is expressed in mammary epithelial cells undergoing EMT during mammary gland development [13] and that phosphorylation of SMAD1/5/9 was found in patients with breast cancer bone metastasis [17] . BMPs activate canonical BMP signaling in normal and tumor mammary epithelial cells [20] , and the canonical BMP signaling mediates migration of normal mammary epithelial cells and invasion of tumor mammary epithelial cells [17, 20] . Moreover, the canonical BMP signaling regulates the cellular proliferation both of normal mammary epithelial cells including MCF-10A cells and tumor mammary epithelial cells [21, 22] . However, it is not well understood whether cadherin switching contributes to the biological processes that are mediated via BMP signaling.
Here, we showed that the expression of E-cadherin is reduced in MCF-10A cells in response to canonical BMP signaling activated by BMP4. In contrast, the expression of Ncadherin is increased in MCF-10A cells following BMP4 treatment. Moreover, BMP4 induces the motility of MCF-10A cells that express N-cadherin. These results suggest that cadherin switching is important for the motility of mammary epithelial cells during normal mammary gland development and metastasis of breast cancer in response to canonical BMP signaling.
Snail superfamily members (e.g., SNAI1 and SNAI2) and TWIST1 have been shown to play a critical role(s) in EMT [18] . It has been well documented that BMP signaling induces EMT following the induction of SNAI2 during various biological processes, e.g., the migration of neural crest cells during normal embryonic development [23] . SNAI2 is a zincfinger transcription factor that mediates the transcriptional repression of E-cadherin to induce EMT [24] . Although Ncadherin expression is down-regulated by both transcriptiondependent [25] and transcription-independent [26] mechanisms, Mani et al. found that N-cadherin expression decreased in SNAI2-expressing cells [27] . We found that BMP4-mediated activation of canonical BMP signaling induced cadherin switching (N-cadherin from E-cadherin) in MCF-10A cells. What is the underlying mechanism(s) of cadherin switching in these cells? Activation of canonical BMP signaling also induces the expression of SNAI2 in MCF-10A cells undergoing EMT. In turn, up-regulation of SNAI2 expression might induce cadherin switching in these cells (inhibition of E-cadherin expression and induction of N-cadherin). However, it is also possible that the stability of N-cadherin proteins is regulated by BMP type I/II receptors activated by a BMP4 ligand through an interaction between BMP type I/II receptors and N-cadherin. For example, N-cadherin inhibits fibroblast growth factor 2 (FGF-2) ligand-mediated internalization of FGF receptors through direct interaction between Ncadherin and FGF receptors, resulting in increased stability of FGF receptors [28] . In contrast, BMP4 stimulates destabilization of N-cadherin via an ADAM-10-dependent mechanism [29] . It would be worthwhile to study whether a BMP4 ligand The polarized distribution and/or expression of tight junction proteins such as ZO-1, claudins, and occludin is lost in epithelial cells undergoing EMT and SNAI2 plays an important role(s) in the regulation of tight junctions during EMT [30] . The expression of claudins and occludin is inhibited and ZO-1 translocates via SNAI2 [30] . We found that BMP4 treatment induced the depolarization of ZO-1 in MCF-10A cells after 30 min as well as 24 h. This finding suggests that BMP4 is able to induce depolarization of ZO-1 independent of the transcriptional activation of EMT mediators. The rapid depolarization of ZO-1 could be explained by the BMP4 ligand-mediated activation of BMP type I/II receptors, which destabilizes polarized tight junction proteins and cell polarity proteins such as Par6. A recent study showed that TGF-β-mediated activation of type II receptors directly results in phosphorylation of Par6, which in turn forms a complex with Smurf1 in TGF-β-dependent EMT. The Par6/Smurf1 complex induces depolarization of tight junctions through localized degradation of RhoA [4] . It would be interesting to further investigate whether BMP4-mediated activation of BMP type I/II receptors mediates the disruption of the polarity of ZO-1.
We also found that only MCF-10A cells that expressed Ncadherin migrated into type I collagen gels in response to BMP4. These results suggest that N-cadherin mediates the cellular motility of MCF-10A cells. It has been shown that N-cadherin promotes cell motility of breast cancer cells through FGF receptor signaling, regardless of E-cadherin expression [31, 32] . It has also been reported that N-cadherin enhances breast cancer metastasis via ERK MAPK signaling [33] . We observed that ERK MAPK was activated in MCF-10A cells in response to BMP4 treatment (data not shown). It would be very important and interesting to study the mechanism(s) of N-cadherin-mediated migration of MCF-10A cells in further studies.
